World’s first AI‑designed vaccine explained | The-14

AI-designed vaccines may protect against future coronavirus variants and emerging threats. Early human trials show promise, but larger studies are needed.

The-14 Pictures

🩺📚 Medical knowledge is growing faster than ever - but finding the right information remains a major challenge.
In the Software Campus project INDEX, Joshua Oehms, together with the @tu_muenchen and #Holtzbrinck explores how AI and domain-specific semantic structures can improve access to biomedical literature and support evidence-based research. 🔬💡

Discover more here:
https://softwarecampus.de/en/projekt/index-integration-of-domain-specific-concepts-and-extracted-knowledge-for-the-structured-visualization-of-medical-literature/

#SoftwareCampus #HealthTech #AI #MedicalResearch

Richard Scolyer remembered by peers for contributions to cancer treatment
By Jacinta Bowler and Peter de Kruijff

Before being diagnosed with cancer, the 2024 Australian of the Year was a leading melanoma researcher, developing better therapies for those with the disease.

https://www.abc.net.au/news/science/2026-06-09/richard-scolyer-research-melanoma-brain-cancer-immunotherapy/105761702

#Cancer #SkinCancer #BrainTumour #ScienceandTechnology #MedicalResearch #Health #JacintaBowler #PeterdeKruijff

How Richard Scolyer made his mark in melanoma research

Before being diagnosed with cancer, the 2024 Australian of the Year was a leading melanoma researcher, developing better therapies for those with the disease.

Muscle growth drug ‘could reduce loss of lean tissue’ when using slimming jabs

Trial suggests monoclonal antibody can help retain lean body mass when losing weight with GLP-1 medicines

The Guardian
Monday briefing: Are we any closer to a cure for cancer?

In today’s newsletter: ​Researchers are giving us new insights into early detection and treatments, but with access to life-saving care remaining uneven patients still have a long road ahead

The Guardian

What is glioblastoma and why is it so hard to treat?
By Caitlyn Davey

Glioblastoma claims the lives of 200,000 people each year globally. Despite decades of research and funding, survival rates remain low.

https://www.abc.net.au/news/health/2026-06-08/what-glioblastoma-is-and-why-is-it-so-hard-to-treat-/106354684

#MedicalResearch #Health #Cancer #BrainTumour #BrainandNervousSystem #CaitlynDavey

What is glioblastoma and why is it so hard to treat?

Glioblastoma claims the lives of 200,000 people each year globally. Despite decades of research and funding, survival rates remain low. 

Richard Scolyer, cancer researcher and former Australian of the year, dies aged 59
By Guardian staff

Scolyer, who did pioneering work on immunotherapy, was diagnosed with inoperable brain cancer in 2023

https://www.theguardian.com/australia-news/2026/jun/08/richard-scolyer-cancer-researcher-and-former-australian-of-the-year-dies-aged-59

#Australianews #Cancerresearch #Cancer #Medicalresearch #Science #Health #Guardianstaff

Richard Scolyer, cancer researcher and former Australian of the year, dies aged 59

Scolyer, who did pioneering work on immunotherapy, was diagnosed with inoperable brain cancer in 2023

The Guardian

If we are to counter medical misogyny, women can no longer be treated as unreliable witnesses of their own experience | Alison Downham Moore
By Alison Downham Moore

The history of gynaecology fuses innovation, authority and violation – and radical surgery is not the unavoidable answer to suffering

https://www.theguardian.com/commentisfree/2026/jun/07/medical-misogyny-women-experiences

#Womenshealth #Women #Doctors #Health #Medicalresearch #Hysterectomy #Reproductiverights #AlisonDownhamMoore

If we are to counter medical misogyny, women can no longer be treated as unreliable witnesses of their own experience

The history of gynaecology fuses innovation, authority and violation – and radical surgery is not the unavoidable answer to suffering

The Guardian